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At a Glance Commentary  
Scientific Knowledge on the Subject: 
The lung clearance index has been suggested as a surrogate for chest computed tomography 
to detect structural lung abnormalities in individuals with cystic fibrosis, however the 
associations between lung clearance index and early structural lung disease are unclear.  
 
What This Study Adds to the Field: 
This study is the first to examine the associations between lung clearance index and structural 
lung disease detected on chest computed tomography across the entire paediatric age range. 
Our data indicates that the lung clearance index is sensitive to the presence and extent of 
structural lung disease in preschool and school-aged children with CF, but is not sensitive to 
mild structural abnormalities in infancy. The lung clearance index may be a useful tool to 
monitor structural disease progression, and an important outcome measure in clinical trials in 
young children with cystic fibrosis. However, our data indicate that lung clearance index 
should not be used as a surrogate to chest imaging to screen for bronchiectasis in children 
with cystic fibrosis. 
 
This article has an online data supplement, which is accessible from this issue's table of 
content online at www.atsjournals.org. 
 
 Abstract 
Rationale: The lung clearance index is a measure of ventilation distribution from the multiple 
breath washout technique. Lung clearance index has been suggested as a surrogate for chest 
computed tomography to detect structural lung abnormalities in individuals with cystic 
fibrosis, however the associations between lung clearance index and early structural lung 
disease are unclear.  
Objective: We assessed the ability of lung clearance index to reflect structural lung disease on 
chest computed tomography across the entire paediatric age range.  
Methods: Lung clearance index was assessed in 42 infants (0-2y), 39 preschool (3-6y), and 
38 school-aged (7-16y) children with cystic fibrosis prior to chest computed tomography, and 
72 healthy controls. Scans were evaluated for CF-related structural lung disease using the 
PRAGMA quantitative outcome measure. 
Measurements and Main Results: In infants with cystic fibrosis, lung clearance index is 
insensitive to structural disease (Kappa -0·03 (-0·05, 0·16)). In preschool children with cystic 
fibrosis, lung clearance index correlates with total disease extent. In school-aged children 
lung clearance index correlates with extent of total disease, bronchiectasis, and air trapping. 
In preschool and school aged children, lung clearance index has a good positive (83-86%), 
but poor negative (50-55%), predictive value to detect the presence of bronchiectasis. 
Conclusions: These data suggest lung clearance index may be a useful surveillance tool to 
monitor structural lung disease in preschool and school age children with cystic fibrosis. 
However, lung clearance index cannot replace chest imaging using computed tomography to 
screen for bronchiectasis in this population. 
 
Abstract word count: 247 
Keywords: Multiple breath washout, infant, child, imaging, cystic fibrosis. 
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 Introduction 
Structural lung abnormalities develop early in individuals with cystic fibrosis (CF) and 
progress rapidly into irreversible structural disease (1-3). To delay the onset and progression 
of lung disease interventions should ideally commence early in life.  However, effective and 
personalised interventions require accurate and simple means to monitor disease severity (4). 
As such there is a clear imperative for the development of minimally invasive and sensitive 
markers of structural lung disease that can be applied routinely in the clinical setting.   
 
Chest computed tomography (CT) is the gold standard for assessing the presence and extent 
of CF-related structural lung disease (1, 3), and outcome measures appropriate for infants and 
young children with mild disease have recently been developed (5). However, despite 
ongoing improvements in technology resulting in lower doses (6, 7), the use of ionising 
radiation limits the frequency at which CT can be performed. Alternative techniques, such as 
lung function measurements, may allow the assessment of lung disease at more frequent 
intervals, reduce the number of CT scans required for the monitoring of structural lung 
disease progression in early life, and serve as endpoints for clinical trials. 
 
Spirometry, particularly forced expiratory volume in 1 second (FEV1), is the most widely 
used method of monitoring CF lung disease.. However FEV1 is insensitive to detect the onset 
and progression of early CF lung disease (8), and difficult to obtain reliably in infants and 
young children (9, 10). 
 
Lung clearance index (LCI) is a marker of global ventilation distribution derived from the 
multiple breath washout technique (MBW). LCI is elevated in a small proportion of infants 
(11, 12), and the majority of preschool (13, 14) and school aged (8, 15) children with CF. In 
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 older children with CF, LCI has been shown to be more sensitive than FEV1 to detect the 
presence of structural lung disease (8, 16, 17). However, there are only weak correlations 
between LCI and structural lung disease in infants with CF (18) and there are no data on the 
ability of LCI to indicate the presence or severity of structural lung disease in preschool 
children aged three to six years. This is arguably the most important age group due to the 
rapid progression of structural disease during this period (3). For LCI to be considered as a 
routine clinical investigation or outcome measure for intervention trials, further evidence 
regarding the ability of LCI to accurately reflect structural lung damage in infants and 
children with CF of all ages is required. The aim of this study was to assess the associations 
between MBW outcomes and CF-related structural lung disease across the entire paediatric 
age range. We hypothesized that the associations between MBW outcomes and structural 
lung disease would be age dependent, with stronger associations seen in older children with 
more established CF-related lung disease. Some of the results of these studies have been 
previously reported in the form of abstracts (19, 20). 
 
 
Methods 
Study population 
Infants and children with CF undergoing annual surveillance or clinically indicated chest CT 
scan at Princess Margaret Hospital in Perth and the Royal Children’s Hospital in Melbourne, 
Australia were eligible to take part in this study (detailed methods are provided in the online 
data supplement). Healthy children without CF over the age of two years were recruited from 
the local population in Perth to undertake lung function measurements. The ethics committee 
of each institution approved the study, and parents gave written informed consent to each 
aspect of the study separately. 
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 Multiple Breath Washout  
The Exhalyzer D system was used for MBW data collection (Ecomedics AG, Duernten, 
Switzerland). Infant MBW (3 months to two years) was performed in the supine position 
using 4% sulphur-hexafluoride (SF6) while asleep following chloral hydrate sedation (18, 
21). In children over two years, MBW was performed using 100% oxygen to washout 
resident nitrogen gas from the lungs (22). Functional residual capacity (FRC), LCI, the first 
(M1/M0) and second (M2/M0) moment ratios were derived from visits with at least two 
acceptable measurements with no evidence of leak or irregular breathing pattern (23). The 
lung clearance index was considered the primary outcome from MBW testing in this study. 
 
Chest Computed Tomography 
Chest CT was only obtained in patients with CF. CT scans in infants and preschool children 
were performed prior to bronchoalveolar lavage collection under intravenous general 
anaesthetic. Volumetric inspiratory scans were obtained at a positive airway opening pressure 
of 25 cmH20, and volumetric or limited slice expiratory scans obtained at an airway opening 
pressure of 0 cmH2O (i.e. relaxed end expiratory volume) (3, 24). In school-aged children, 
spirometry-assisted volumetric chest CT scans were obtained, whereby inspiratory scans 
were obtained at total lung capacity and expiratory scans were collected at residual volume 
(25). 
 
To assess CT-determined structural lung disease, the quantitative PRAGMA-CF scoring 
method was used (5).  Briefly, a grid overlaid on ten equidistant axial slices is annotated for 
the presence of bronchiectasis (outer edge bronchus-artery cross-sectional area ratio > 1), 
mucus plugging (high density airway occlusion or tree-in-bud appearance), bronchial wall 
thickening (assessed subjectively as airway walls that are thicker or have increased signal 
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 density relative to normal airways) on inspiratory scans, and trapped air (geographic low 
density regions) on expiratory scans (5). The extents (represented as volume proportions of 
the lung) of total airways disease (% disease), bronchiectasis (% bronchiectasis) and trapped 
air (% air trapping) were calculated and considered the primary outcome from chest CT. 
Chest CT scans were also scored for the presence and extent of bronchiectasis, mucus 
plugging, bronchial wall thickening and air trapping using a simplified CF-CT scoring 
method as described previously (2, 3). 
 
Statistical analysis  
The upper limit of normal for MBW indices were calculated from a prospective healthy 
control population of preschool and school aged children (n = 72) and published reference 
equations for infants (LCI only as there are no reference data are available for moment ratios 
in infants) (26). The agreement between MBW indices and the presence of bronchiectasis and 
air trapping was assessed using the Kappa coefficient of agreement and receiver operating 
characteristic (ROC) curves. Sensitivity, specificity, positive and negative predictive values 
were calculated together with 95% exact binomial confidence intervals. Associations between 
MBW indices and the extent of structural lung disease were assessed using linear mixed 
effects models with random intercepts for repeated visits to account for clustering. The 
coefficients of the fixed effects of the linear mixed models, with 95% confidence intervals 
and p-values are presented. All analyses were performed using Stata 13.0 (Stata Corp. 2013, 
College Station, TX). 
 
 
Results 
Study population 
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 Matched MBW and chest CT data were available for 49 visits in 42 infants (3 months to two 
years), 52 visits in 39 preschool children (three to six years) and 48 visits in 38 school-aged 
children (seven to 16 years) with CF (Table 1). In addition, MBW data were available on a 
prospective healthy control population of 72 preschool and school aged children (three to 15 
years) with no history of respiratory disease (Table E1 in the online data supplement). In the 
control population LCI, M1/M0 and M2/M0 were found to be independent of height or age 
(Figure 1). We found that 22% of infants, 58% of preschool and 58% of school-aged children 
with CF had an LCI above the upper limit of normal (Table 2). 
 
Agreement between MBW indices and the presence of bronchiectasis 
The agreement between LCI and the presence of bronchiectasis on chest CT is shown in 
Table 2. An abnormal LCI and detectable bronchiectasis was uncommon in infants with CF 
resulting in a low sensitivity and low positive predicted value. The majority of preschool and 
school aged children with CF had an LCI above the upper limit of normal (58%) and had 
bronchiectasis detected on CT (69%), resulting in a high concordance between the two 
measures (~70%). In these older age groups LCI had a sensitivity and specificity of ~70% to 
detect bronchiectasis. The positive predictive value for LCI was high indicating that in over 
80% of visits when LCI is abnormally elevated bronchiectasis can be detected on chest CT. 
However, the negative predictive value of LCI was low (50-55%) indicating that in half of 
the visits where LCI is within the normal range bronchiectasis was still detected on CT. The 
results for the moment ratios were similar to that of LCI and are presented in Table E2 in the 
online data supplement. In addition, we performed an ROC analysis for LCI and the presence 
of bronchiectasis (Table E3 in the online data supplement). We determined the optimal LCI 
value (calculated to maximise sensitivity and specificity) to detect bronchiectasis, to be 7.8 
lung turnovers for each age group. 
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 Agreement between MBW indices and the presence of air trapping 
The agreement between LCI and the presence of air trapping on chest CT is shown in Table 
3. The prevalence of air trapping increased with age from 58% in infants, 85% in preschool 
children, and 94% in school-age children. There was significant agreement between LCI and 
the presence of air trapping on CT in infants with CF. However the sensitivity of LCI to 
detect air trapping on CT was only 38%. There was no agreement between LCI and air 
trapping presence in preschool and school-aged children with CF. In preschool children, LCI 
had a lower positive (73%) and negative (41%) predictive value to detect air trapping 
presence than in infants. In school-aged children, LCI had a high positive (93%), but almost 
negligible negative (5%) predictive value to detect air trapping. The results for the moment 
ratios were similar to that of LCI and are presented Table E4 in the online data supplement. 
 
Associations between MBW outcomes and extent of structural disease 
We examined the association between MBW outcomes and the extent of structural disease 
abnormalities on chest CT using PRAGMA-CF scores (Table 4; Figure 2). In infants with 
CF, LCI and M1/M0 did not correlate with any structural disease extent scores. There was, 
however, a significant association between M2/M0 and the extent of bronchiectasis and air 
trapping. In preschool children with CF, LCI positively correlated with total structural disease 
extent but not the extent of bronchiectasis or air trapping. Both M1/M0 and M2/M0 in 
preschool children correlated with total structural disease and bronchiectasis extent, but not 
air trapping. In school-aged children with CF, LCI and M2/M0 positively correlated with 
total disease, bronchiectasis, and air trapping extent. M1/M0 did not correlate with any 
disease extent scores in school-aged children. We found similar associations between MBW 
outcomes and structural disease extent scores using the simplified CF-CT scoring method 
(Table E5 in the online data supplement). 
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 Discussion 
The objective of this study was to determine the ability of MBW measures of ventilation 
distribution to act as a minimally invasive surrogate for structural lung disease in children 
with CF. We compared MBW outcomes against chest CT, the current gold standard method 
to detect structural lung disease in CF. We found that LCI is relatively insensitive to the 
presence and extent of early structural abnormalities in infants with CF. In preschool and 
school-aged children, LCI had good agreement and correlation with the presence and extent 
of structural abnormalities on CT. However, the low negative predictive value of LCI for the 
presence of bronchiectasis and air trapping in infants and children with CF suggests that LCI 
should not be used as a surrogate for chest CT to indicate the presence of structural disease. 
Despite the limitations of LCI to identify lung damage, LCI could be a useful tool for 
monitoring early lung disease in CF, and therefore longitudinal assessments of LCI in relation 
to other clinical outcomes including inflammation, infection and structural lung disease 
trajectory are needed. 
 
We found that LCI was relatively insensitive to the presence and extent of structural lung 
disease in infants with CF. This supports data from a previous study by our group, that 
examined associations between LCI, moment ratios and structural lung disease on limited 
slice chest CT scans scored using a CF-CT scoring method modified for use in children (18). 
This study found a weak correlation between LCI, moment ratios and the extent of air 
trapping on CT (18). Our current study utilised volumetric chest CT scans, that have been 
shown to be more sensitive to detect early structural lung disease, and the PRAGMA-CF 
scoring method that quantifies early structural disease (5). We found that LCI was relatively 
insensitive to detect the presence of bronchiectasis and air trapping on chest CT, and did not 
correlate with any structural disease extent parameter in infants with CF. There was, 
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 however, a correlation between M2/M0 and bronchiectasis and air trapping extent, suggesting 
that moment ratio analysis may be more sensitive to the extent of early disease than LCI. 
Structural lung disease in the first two years of life in infants with CF following newborn 
screening and treatment in a specialist centre is mild; only 20% of infants in our study had 
detectable bronchiectasis and the mean percentage of the lung affected by bronchiectasis was 
0.2%. The prevalence of bronchiectasis in this study is higher than that previously reported 
by our group (3), which is likely due to the greater sensitivity to detect bronchiectasis in 
volumetric scans compared with the 3-slice technique used previously. While the extent of 
structural disease in infants with CF is low, we have previously shown that disease extent is 
associated with more rapid progression of lung disease over the subsequent two years in 
infants with CF, and thus is likely to be clinically relevant (5). The LCI may be more useful 
as a tool to reflect potentially reversible changes in the lungs associated with inflammation 
and infection in this age group (11, 27), but the results from our current study indicate that 
MBW indices are not sufficiently sensitive to be used as a surrogate for the detection and 
monitoring of early structural lung disease in infants with CF.  
 
This study is the most comprehensive examination of the relationships between LCI and 
structural lung disease in infants and preschool children with CF. This developmental period 
is associated with increasing prevalence and extent of structural lung disease along with 
worsening ventilation inhomogeneity (increased LCI) (1, 13, 14). The prevalence of 
bronchiectasis in our population was 69% in preschool children, compared with only 20% in 
infants with CF. Given the rapid increase in the prevalence of bronchiectasis in the preschool 
years, this period arguably represents a window of opportunity for interventions aimed at 
preventing or slowing the development of irreversible structural disease. In the present study 
MBW outcomes, LCI and moment ratios had good agreement, sensitivity and specificity to 
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 detect the presence of bronchiectasis on chest CT. We also found positive correlations 
between MBW outcomes and the extent of structural lung disease. These data suggest that 
MBW outcomes could be used as a surveillance tool for the monitoring of established 
structural disease in children with CF. However, we advise caution regarding the use of LCI 
as a screening tool or surrogate for chest CT to detect the presence of structural lung disease. 
While we found that the majority of children with an abnormal LCI had bronchiectasis 
detected on their CT (positive predictive value = 83%), we found that only half of the 
children with an LCI within the normal range did not have bronchiectasis detected on CT 
(negative predictive value = 50%). This means that a significant portion of children would be 
misdiagnosed as not having bronchiectasis if LCI was used as the sole screening/detection 
tool. We believe that the LCI would be ideally suited as a non-invasive monitoring tool for 
preschool children with CF that could be applied regularly in the clinical setting in 
conjunction with imaging techniques for the detection and monitoring of structural disease.  
 
These data support previous studies regarding the ability of LCI to reflect structural disease in 
school-aged children with CF. We found that LCI and moment ratios correlated with the 
presence and extent of structural lung disease in school-aged children with CF, as has been 
reported previously (8, 16, 17). We found that over 85% of children with an abnormal LCI 
had bronchiectasis detected on chest CT. However, the negative predictive value of LCI was 
again low (55%) indicating that in half of the visits where LCI was normal, bronchiectasis 
was still detected on CT. In a study of individuals with CF aged five to 19 years, LCI had a 
lower positive (71%) and higher negative predictive (69%) to detect the presence of 
bronchiectasis on CT compared with the present study (8). In individuals with CF aged six to 
26 years with a normal FEV1 (>80% predicted), LCI had a positive predictive value of 88% 
and negative predictive value of 63% to detect an abnormal chest CT (16). Similarly, in a 
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 younger cohort of school-aged children (6 – 10 years) LCI had a positive predictive value of 
88% and negative predictive value of 44% to reflect an abnormal chest CT (17). It is 
important to note that positive and negative predictive values are dependent on the prevalence 
of structural lung disease in the population and may not be generalizable to a population with 
a different prevalence. Together these data support the notion that an abnormal LCI is highly 
predictive of the presence of structural lung disease, however, an LCI within the normal 
range does not rule out structural lung disease detected on chest CT. 
 
Strengths of the present study include the use of a prospective healthy control cohort for the 
calculation of upper limits of normal for LCI and moment ratios in preschool and school-aged 
children. In infants with CF, the second moment ratio was more strongly correlated with the 
extent of structural lung disease than LCI, possibly because moment ratios can detect more 
peripheral ventilation inhomogeneity at the latter portion of the washout compared with LCI. 
As a result moment ratios may be most valuable to calculate in early life where the disease is 
dominated by small changes to the peripheral airways. We also utilised the novel PRAGMA-
CF quantitative CT scoring method, aimed specifically at quantifying the extent of early 
structural abnormalities in early CF lung disease (5). While we did not see any appreciable 
difference in the structure-function extent relationships between PRAGMA and CF-CT 
scores, we believe that the PRAGMA-CF is the most appropriate method for assessing CT 
scans in young children with CF. Limitations of the current study include the differences in 
the MBW testing in infancy (sedated, supine, SF6 gas) compared with children (awake, 
seated, 100% oxygen to washout resident nitrogen gas). Sedation during lung function may 
have caused atelectasis or air trapping. It is also possible that the use of an exogenous tracer 
gas (SF6) for MBW testing in infancy could underestimate ventilation inhomogeneity due to 
the SF6 gas not penetrating occluded lung units. In addition there were difference in chest CT 
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 scanning techniques in infants and preschool (anaesthetised, expiratory scan at functional 
residual capacity) and school-age (awake, spirometry-assisted, expiratory scan at residual 
volume). Our study aimed to determine if LCI could be used as a surrogate for chest CT to 
detect structural disease, and thus was not designed to examine the effect of clinical variables, 
such as pulmonary infection status, inflammation, or exacerbations on the associations 
between MBW and CT outcomes. All the children in our study, including the three 
adolescent patients who underwent clinically indicated chest CT scans, were clinically stable 
at the time of CT and MBW testing. Current studies that have examined relations between 
LCI and structural lung disease have been cross-sectional in nature, and thus we are not yet 
able to determine whether LCI can track the development and progression of structural lung 
disease over time.  
 
Treatment and monitoring of lung disease should commence early in life in individuals with 
CF in order to prevent the onset and/or slow the progression of lung disease. The LCI is a 
promising lung function outcome that can be measured across the entire paediatric age range. 
The results from this study suggest that the LCI is sensitive to detect the presence and extent 
of structural lung disease detected by chest CT in preschool and school-aged children with 
CF, but is not sensitive to detect mild structural abnormalities in infancy. While LCI may be a 
useful surveillance tool in CF and potentially a feasible clinical trial outcome, our data 
indicate that LCI should not be used as a surrogate to chest imaging for the detection of 
bronchiectasis in children with CF. 
 
Acknowledgements: The authors thank Caroline Gallagher, Jasmine Grdosic and the 
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 Figure legends 
Figure 1: Lung clearance index plotted against age for healthy control children (circles) and 
children with cystic fibrosis (triangles). LCI = lung clearance index. Horizontal lines indicate 
the upper (7.7) and lower (5.7) limits of normal for LCI. 
 
Figure 2: Scatter plots of LCI plotted against % disease, % bronchiectasis, and % air 
trapping scores in infants (A – red markers), preschool  (B – green markers) and school-aged 
(C – blue markers) children with CF. LCI = lung clearance index. 
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 Tables 
Characteristics Infants Preschool School-age 
Number of children 42 39 38 
Number of visits 49 52 48 
Age (y) 0·94 (0·57) 5·42 (1·05) 9·77 (2·48) 
Sex [male: female] 16 : 26 16 : 23 21 : 17 
Height z-score (95% CI) 0·03 (-0·20, 0·28) 0·08 (-0·20, 0·34) -0·20 (-0·44, 0·04) 
Weight z-score (95% CI) -0·12 (-0·33, 0·53) 0·19 (-0·13, 0·51) 0·26 (-0·04, 0·55) 
FEV1 L (95% CI)   1.80 (1.65, 1.95) 
FEV1 z-score (95% CI)   -0.13 (-0.51, 0.26) 
FVC L (95% CI)   2.19 (2.03, 2.34) 
FVC z-score (95% CI)   0.23 (-0.12, 0.57) 
Phe508del/Phe508del 58% (25/42) 62% (25/39) 54% (21/38) 
Phe508del/other 36% (16/42) 30% (12/39) 35% (14/38) 
Severe genotype 88% (38/42) 91% (35/39) 88% (34/38) 
Multiple Breath Washout 
Functional residual 
capacity 0.19 (0.08) 0.91 (0.19) 1.51 (0.77) 
Lung clearance index 7·81 (0·80) 8·17 (1·22) 8·35 (1·78) 
First moment ratio 2·30 (0·28) 1·78 (0·24) 1·95 (0·91) 
Second moment ratio 11·02 (4.16) 8·80 (2·05) 7·19 (3·41) 
PRAGMA-CF scores 
Bronchiectasis present 20% (10/49) 69% (36/52) 69% (33/48) 
Air trapping present 58% (29/49) 85% (44/52) 94% (45/48) 
Bronchiectasis extent (%) 0·18 (0·34) 1·88 (3·38) 2·05 (3·21) 
Air trapping extent (%) 1·35 (2·73) 6·37 (12·02) 20·8 (21·34) 
Disease extent (%) 1·35 (1·05) 4·26 (4·29) 4·86 (5·13) 
    20 
 Table 1: Demographics of study population Data is presented as mean (standard deviation) 
or % (proportion) unless otherwise stated. 95% CI = 95% confidence interval. Height, weight 
and BMI z-scores were calculated using WHO growth standards (28, 29)
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Table 2: Agreement between LCI and the presence of bronchiectasis on chest CT using 
PRAGMA-CF scores. Brackets contain n values or 95% confidence interval. LCI = lung 
clearance index; ULN = upper limit of normal. Upper limit of normal for LCI in infants was 
derived from the equation in Lum et al. 2013. The upper limit of normal for LCI in preschool 
and school-age children was derived from our prospective healthy population (Table E1 in 
the online data supplement). * p < 0·05; # p < 0·01; Φ p < 0·001. 
 
  
 Infant Preschool School-age 
LCI ULN 
Derived from          
Lum et al. 2013 
7.7 7.7 
Abnormal LCI (%) 22% (11/49) 58% (30/52) 58% (28/48) 
Bronchiectasis 
present 
20% (10/49) 69% (36/52) 69% (33/48) 
Concordance (%) 65% (32/49) 69% (36/52) 73% (35/48) 
Kappa coefficient -0·03 (-0·05, 0·16) 0·35 (0·10, 0·60) # 0·42 (0·20, 0·64) # 
Sensitivity 20% (2·5, 56) 69% (52, 84) 73% (55, 87) 
Specificity 77% (61, 89) 69% (41, 89) 73% (45, 92) 
Positive predictive 
value 
18% (2.3, 52) 83% (65, 94) 86% (67, 96) 
Negative predictive 
value 
79% (63, 90) 50% (28, 72) 55% (32, 77) 
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 Table 3: Agreement between LCI and the presence of air trapping on chest CT using 
PRAGMA-CF scores. Brackets contain n values or 95% confidence interval. LCI = lung 
clearance index; ULN = upper limit of normal. Upper limit of normal for LCI in infants was 
derived from the equation in Lum et al. 2013. The upper limit of normal for LCI in preschool 
and school-age children was derived from a prospective healthy population (Table E1 in the 
online data supplement). p < 0·05; # p < 0·01; Φ p < 0·001. 
 
 
 
  
 Infant Preschool School-age 
LCI ULN 
Derived from          
Lum et al. 2013 
7.7 7.7 
Abnormal LCI (%) 22% (11/49) 58% (30/52) 58% (28/48) 
Air trapping 
present 
58% (29/49) 85% (44/52) 94% (45/48) 
Concordance (%) 65% (32/49) 60% (31/52) 56% (27/48) 
Kappa coefficient 0·30 (0·06, 0·54) Φ 0·15 (-0·13, 0·43)  -0·02 (-0·16, 0·14)  
Sensitivity 38% (19, 59) 63% (45, 79) 58% (42, 72) 
Specificity 92% (74, 99) 53% (28, 77) 33% (0·84, 91) 
Positive predictive 
value 
82% (48, 98) 73% (54, 88) 93% (77, 99) 
Negative predictive 
value 
61% (43, 76) 41% (21, 64) 5% (0·13, 25) 
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  LCI M/M0 M2/M0 
Infants 
% Disease 0·03 (-0·14, 0·20) 0·00 (-0·01, 0·01) 0·02 (0·04, 0·16) 
% Bronchiectasis -0·33 (-0·82, 0·16) 0·01 (-0·02, 0·04)  0·31 (0·18, 0·45) Φ 
% Air trapping 0·04 (-0·04, 0·12) 0·00 (-0·00, 0·01) 0·05 (0·03, 0·08) Φ 
Preschool 
% Disease 0·10 (0·02, 0·19) * 0·02 (0·00, 0·04) * 0·17 (0·03, 0·31) * 
% Bronchiectasis 0·11 (0·00, 0·22)  0·02 (0·00, 0·05) *  0·20 (0·01, 0·39) * 
% Air trapping 0·02 (-0·01, 0·05) 0·00 (0·00, 0·01) 0·02 (-0·03, 0·07) 
School-age 
% Disease 0·18 (0·10, 0·27) Φ 0·03 (-0·02, 0·08) 0·36 (0·19, 0·53) Φ 
% Bronchiectasis 0·29 (0·14, 0·43) Φ 0·04 (-0·05, 0·13)  0·55 (0·28, 0·83) Φ 
% Air trapping 0·06 (0·04, 0·07) Φ 0·01 (-0·01, 0·02) 0·10 (0·06, 0·14) Φ 
Table 4: Association between MBW outcomes and the extent of structural disease on 
CT using PRAGMA-CF scores. Brackets contain 95% confidence interval. LCI = lung 
clearance index; M1/M0 = first moment ratio; M2/M0 = second moment ratio. Coefficients 
indicate the increase in MBW outcomes for each unit increase in CT outcomes. * p < 0·05; # 
p < 0·01; Φ p < 0·001. 
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 Figures  
 
Figure 1: Lung clearance index plotted against age for healthy control children (circles) and 
children with cystic fibrosis (triangles). LCI = lung clearance index. Horizontal lines indicate 
the upper (7.7) and lower (5.7) limits of normal for LCI.  
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 Figure 2: Scatter plots of LCI plotted against % disease, % bronchiectasis, and % air trapping scores in infants (A – red markers), preschool  (B 
– green markers) and school-aged (C – blue markers) children with CF. LCI = lung clearance index.  
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